PRISCILLA DUERSTOCK: Open Payments
NPI 1184175044 · LOGAN TWP, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$234 in 13 payments from 7 companies in 2025. Trend: 2023 $50 · 2024 $297 · 2025 $234
Food & beverage: $234
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Vanda Pharmaceuticals Inc. | 2 | $34 |
| Almatica Pharma LLC | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| ABBVIE INC. | 1 | $23 |
Products named: COBENFY, REXULTI, FANAPT, LOREEV XR, CAPLYTA, VRAYLAR, AUSTEDO XR, UZEDY.
Industry payments across NJ — which companies pay providers there.
